Avidity Partners Management as of June 30, 2022
Portfolio Holdings for Avidity Partners Management
Avidity Partners Management holds 82 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Astrazeneca Sponsored Adr (AZN) | 5.3 | $231M | 3.5M | 66.07 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 5.1 | $224M | 793k | 281.79 | |
| Argenx Se Sponsored Adr (ARGX) | 5.0 | $217M | 573k | 378.88 | |
| Anthem (ELV) | 4.9 | $213M | 441k | 482.58 | |
| Avantor (AVTR) | 4.7 | $207M | 6.7M | 31.10 | |
| Eli Lilly & Co. (LLY) | 4.5 | $198M | 610k | 324.23 | |
| Humana (HUM) | 4.4 | $193M | 412k | 468.07 | |
| United Therapeutics Corporation (UTHR) | 3.9 | $171M | 726k | 235.64 | |
| Johnson & Johnson (JNJ) | 3.7 | $160M | 900k | 177.51 | |
| Horizon Therapeutics Pub L SHS | 3.4 | $148M | 1.9M | 79.76 | |
| Neurocrine Biosciences (NBIX) | 3.3 | $143M | 1.5M | 97.48 | |
| Arvinas Ord (ARVN) | 3.2 | $141M | 3.4M | 42.09 | |
| Spdr Ser Tr S&p Biotech (XBI) | 3.2 | $139M | 1.9M | 74.27 | |
| McKesson Corporation (MCK) | 2.9 | $127M | 389k | 326.21 | |
| UnitedHealth (UNH) | 2.9 | $124M | 242k | 513.63 | |
| Abbvie (ABBV) | 2.7 | $116M | 755k | 153.16 | |
| Syndax Pharmaceuticals (SNDX) | 2.4 | $105M | 5.5M | 19.24 | |
| Catalent (CTLT) | 2.4 | $103M | 955k | 107.29 | |
| Zentalis Pharmaceuticals (ZNTL) | 2.3 | $101M | 3.6M | 28.10 | |
| Seagen | 2.2 | $97M | 550k | 176.94 | |
| Boston Scientific Corporation (BSX) | 2.2 | $94M | 2.5M | 37.27 | |
| Biogen Idec (BIIB) | 2.1 | $90M | 441k | 203.94 | |
| Ultragenyx Pharmaceutical (RARE) | 2.0 | $88M | 1.5M | 59.66 | |
| Acadia Healthcare (ACHC) | 1.6 | $70M | 1.0M | 67.63 | |
| Intellia Therapeutics (NTLA) | 1.3 | $58M | 1.1M | 51.76 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 1.3 | $55M | 1.0M | 55.00 | |
| Arrowhead Pharmaceuticals (ARWR) | 1.2 | $51M | 1.4M | 35.21 | |
| Immunocore Hldgs Ads (IMCR) | 1.2 | $50M | 1.4M | 37.31 | |
| Natera (NTRA) | 1.1 | $49M | 1.4M | 35.44 | |
| Intra Cellular Therapies (ITCI) | 1.0 | $44M | 776k | 57.08 | |
| Ideaya Biosciences (IDYA) | 0.9 | $41M | 3.0M | 13.80 | |
| Bellus Health Com New | 0.9 | $39M | 4.3M | 9.24 | |
| Altimmune Com New (ALT) | 0.8 | $35M | 3.0M | 11.70 | |
| Kezar Life Sciences (KZR) | 0.8 | $34M | 4.1M | 8.27 | |
| Avidity Biosciences Ord (RNA) | 0.7 | $30M | 2.1M | 14.53 | |
| Karuna Therapeutics Ord | 0.6 | $26M | 205k | 126.51 | |
| Revolution Medicines (RVMD) | 0.6 | $26M | 1.3M | 19.49 | |
| Ark Etf Tr Genomic Rev Etf (ARKG) | 0.5 | $24M | 750k | 31.49 | |
| Vir Biotechnology (VIR) | 0.4 | $19M | 758k | 25.47 | |
| Nkarta (NKTX) | 0.4 | $17M | 1.4M | 12.32 | |
| Phathom Pharmaceuticals (PHAT) | 0.4 | $16M | 1.9M | 8.44 | |
| Caribou Biosciences (CRBU) | 0.4 | $16M | 3.0M | 5.43 | |
| Deciphera Pharmaceuticals (DCPH) | 0.4 | $16M | 1.2M | 13.15 | |
| Nuvation Bio Com Cl A (NUVB) | 0.4 | $16M | 4.9M | 3.24 | |
| Iovance Biotherapeutics (IOVA) | 0.4 | $15M | 1.4M | 11.04 | |
| Xenon Pharmaceuticals (XENE) | 0.3 | $14M | 450k | 30.42 | |
| Si-bone (SIBN) | 0.3 | $13M | 1.0M | 13.20 | |
| Seaspine Holdings | 0.3 | $11M | 2.0M | 5.65 | |
| Alphatec Hldgs Com New (ATEC) | 0.3 | $11M | 1.7M | 6.54 | |
| Apellis Pharmaceuticals (APLS) | 0.2 | $9.7M | 215k | 45.22 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.2 | $9.7M | 62k | 156.02 | |
| Alpine Immune Sciences (ALPN) | 0.2 | $8.5M | 999k | 8.51 | |
| Essa Pharma Com New (EPIX) | 0.2 | $7.7M | 2.5M | 3.15 | |
| Century Therapeutics (IPSC) | 0.2 | $7.3M | 865k | 8.40 | |
| Erasca (ERAS) | 0.1 | $5.5M | 995k | 5.57 | |
| Cyteir Therapeutics | 0.1 | $5.5M | 1.9M | 2.99 | |
| An2 Therapeutics (ANTX) | 0.1 | $5.3M | 688k | 7.75 | |
| Compass Therapeutics (CMPX) | 0.1 | $5.3M | 2.0M | 2.65 | |
| Medicus Sciences Acquisition Cl A Shs | 0.1 | $5.1M | 520k | 9.78 | |
| Bcls Acquisition Corp Com Cl A | 0.1 | $5.0M | 500k | 9.90 | |
| Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.1 | $4.9M | 500k | 9.81 | |
| Panacea Acquisition Corp Ii Cl A Shs | 0.1 | $4.9M | 500k | 9.76 | |
| Sentinelone Cl A (S) | 0.1 | $4.8M | 205k | 23.33 | |
| Iveric Bio | 0.1 | $4.1M | 430k | 9.62 | |
| Health Sciences Acq Corp 2 Ord Shs | 0.1 | $4.0M | 400k | 9.96 | |
| Tango Therapeutics (TNGX) | 0.1 | $3.7M | 814k | 4.53 | |
| Hyperfine Com Cl A (HYPR) | 0.1 | $3.4M | 1.5M | 2.23 | |
| Caremax Com Cl A | 0.1 | $2.7M | 755k | 3.63 | |
| Phasebio Pharmaceuticals (PHASQ) | 0.1 | $2.6M | 4.4M | 0.60 | |
| Field Trip Health Ord | 0.1 | $2.5M | 3.0M | 0.84 | |
| Oncosec Medical Incorporated | 0.1 | $2.2M | 2.9M | 0.74 | |
| Otonomy | 0.0 | $2.1M | 1.0M | 2.08 | |
| Social Cap Suvretta Hld Crpi Class A Ord Shs | 0.0 | $2.0M | 200k | 9.95 | |
| Social Cap Suvretta Hlds Crp Class A Ord Shs | 0.0 | $2.0M | 200k | 9.89 | |
| Graphite Bio | 0.0 | $2.0M | 710k | 2.75 | |
| Social Cap Suvretta Hlds Crp Class A Ord Shs | 0.0 | $1.9M | 200k | 9.72 | |
| Social Cap Suvretta Hlds Cp Class A Ord Shs | 0.0 | $1.9M | 200k | 9.71 | |
| Scynexis Com New (SCYX) | 0.0 | $1.8M | 960k | 1.86 | |
| Sema4 Holdings Corp Com Cl A | 0.0 | $1.2M | 950k | 1.26 | |
| Science 37 Holdings | 0.0 | $864k | 430k | 2.01 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $28k | 100k | 0.28 | |
| Medicus Sciences Acquisition *w Exp 02/12/202 | 0.0 | $10k | 58k | 0.17 |
